Stay updated on NKTR-214 Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo with Nivolumab Clinical Trial page.

Latest updates to the NKTR-214 Combo with Nivolumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedGastric cancer was added to the study’s conditions and the page revision was updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

- Check19 days agoChange DetectedA minor site revision updated from v3.4.0 to v3.4.1. No core content or functionality changes were observed on the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedMinor UI and labeling updates were applied, including glossary controls (Show/Hide glossary), capitalization tweaks (Last Update Submitted that Met QC Criteria; No FEAR Act Data vs data), and a new Revision: v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study content or its presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedLocations across multiple US states and Canadian provinces were added and some location entries were removed, and the Revision: v3.3.3 tag was introduced.SummaryDifference1%

- Check91 days agoChange DetectedMinor textual updates clarify that publications are auto-filled from PubMed and update revision notes (v3.2.0 removed; v3.3.2 added); these changes do not affect the study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NKTR-214 Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo with Nivolumab Clinical Trial page.